Abstract
Two developments have drastically changed FDA’s approach to regulation ot topical antimicrobial agents; the recognition of the systematic toxicity of small amounts of hexachlorophene when absorbed after topical application; and the subsequent review and recommendations concerning both safety and effectiveness of other antimicrobial ingredients as part of the FDA review of OTC drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References>
Cade AR (1951) A method for testing the degerming efficacy of hexachlorophene soaps. J Soc Cosmetics Chemists 2:281–290
OTC Antimicrobial Products and Drug and Cosmetic Products. Report of FDA OTC Antimicrobial I Panel. Sept. 13, 1974 Federal Register Vol. 39, No. 179, Part II
OTC Topical Antimicrobial Products, Tentative Final Monograph. Jan. 6, 1979 Federal Register, Vol. 43, No. 4
Price PB (1938) The bacteriology of normal skin: a new quantitative test applied to a study of the bacterial flora and the disinfectant action of mechanical cleansing. J Infect Dis 63:301–318
Quinn H, JG Voss, HS Whitehouse (1954) A method for the in vivo evaluation of skin sanitizing soaps. Appl Microbiol 2:202–204
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Bruch, M. (1981). Newer Germicides: What They Offer. In: Maibach, H.I., Aly, R. (eds) Skin Microbiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5868-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5868-1_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5870-4
Online ISBN: 978-1-4612-5868-1
eBook Packages: Springer Book Archive